Nektar Therapeutics (NKTR) Inventory (2010 - 2024)

Nektar Therapeutics' Inventory history runs 15 years deep, the most recent figure standing at $14.5 million for Q2 2024.

• In Q2 2024, Inventory fell 30.08% year-over-year to $14.5 million; the TTM figure through Jun 2024 stood at $14.5 million (down 30.08% YoY), while the FY2023 annual figure was $16.1 million, down 16.15% from the prior year.
• Inventory was $14.5 million for Q2 2024 at Nektar Therapeutics, down from $16.2 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $20.7 million in Q2 2023 to a low of $12.6 million in Q2 2020.
• Historically, Inventory has averaged $16.2 million across 5 years, with a median of $15.6 million in 2021.
• The sharpest annual moves came in 2023 and 2024: Inventory soared 31.58% in 2023, then slumped 30.08% in 2024.
• A 5-year view of Inventory shows it stood at $15.3 million in 2020, then increased by 3.33% to $15.8 million in 2021, then advanced by 21.52% to $19.2 million in 2022, then slipped by 16.15% to $16.1 million in 2023, then fell by 10.16% to $14.5 million in 2024.
• The last three Inventory figures came in at $14.5 million (Q2 2024), $16.2 million (Q1 2024), and $16.1 million (Q4 2023), per Business Quant data.